Helixmith Co. Ltd
Helixmith Co., Ltd, a biotechnology company, discovers and develops biopharmaceuticals for human diseases. The company has a pipeline of novel biologics and herbal therapeutics in the areas of cardiovascular disease, cancer, and immune disorder, with clinical studies ongoing in the United States, Korea, and China. Its flagship product is VM202, a DNA-based drug for cardiovascular and neurological… Read more
Helixmith Co. Ltd (084990) - Net Assets
Latest net assets as of September 2025: ₩138.57 Billion KRW
Based on the latest financial reports, Helixmith Co. Ltd (084990) has net assets worth ₩138.57 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩144.42 Billion) and total liabilities (₩5.85 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩138.57 Billion |
| % of Total Assets | 95.95% |
| Annual Growth Rate | 7.34% |
| 5-Year Change | -48.59% |
| 10-Year Change | 111.38% |
| Growth Volatility | 45.96 |
Helixmith Co. Ltd - Net Assets Trend (2010–2024)
This chart illustrates how Helixmith Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Helixmith Co. Ltd (2010–2024)
The table below shows the annual net assets of Helixmith Co. Ltd from 2010 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩142.04 Billion | -7.60% |
| 2023-12-31 | ₩153.72 Billion | -29.10% |
| 2022-12-31 | ₩216.80 Billion | -3.79% |
| 2021-12-31 | ₩225.35 Billion | -18.44% |
| 2020-12-31 | ₩276.30 Billion | +41.28% |
| 2019-12-31 | ₩195.57 Billion | +46.09% |
| 2018-12-31 | ₩133.87 Billion | -18.60% |
| 2017-12-31 | ₩164.45 Billion | -3.79% |
| 2016-12-31 | ₩170.93 Billion | +154.37% |
| 2015-12-31 | ₩67.20 Billion | +0.34% |
| 2013-12-31 | ₩66.97 Billion | +3.90% |
| 2012-12-31 | ₩64.45 Billion | +29.47% |
| 2011-12-31 | ₩49.78 Billion | -5.57% |
| 2010-12-31 | ₩52.72 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Helixmith Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 46269128455000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩23.05 Billion | 16.18% |
| Other Components | ₩596.32 Billion | 418.57% |
| Total Equity | ₩142.47 Billion | 100.00% |
Helixmith Co. Ltd Competitors by Market Cap
The table below lists competitors of Helixmith Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cool Company Oy
OL:CLCO
|
$126.25 Million |
|
Hooker Furniture Corporation
NASDAQ:HOFT
|
$126.33 Million |
|
Becamex Infrastructure Development JSC
VN:IJC
|
$126.35 Million |
|
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
SHG:600671
|
$126.36 Million |
|
Nanjing OLO Home Furnishing
SHG:603326
|
$126.15 Million |
|
MNRB Holdings Bhd
KLSE:6459
|
$126.14 Million |
|
Federal Corp
TW:2102
|
$126.14 Million |
|
Daqing Huake Co Ltd
SHE:000985
|
$126.10 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Helixmith Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 154,136,163,840 to 142,467,089,550, a change of -11,669,074,290 (-7.6%).
- Net loss of 15,471,280,150 reduced equity.
- Share repurchases of 3,379,198,260 reduced equity.
- New share issuances of 3,379,198,260 increased equity.
- Other factors increased equity by 3,802,205,860.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-15.47 Billion | -10.86% |
| Share Repurchases | ₩3.38 Billion | -2.37% |
| Share Issuances | ₩3.38 Billion | +2.37% |
| Other Changes | ₩3.80 Billion | +2.67% |
| Total Change | ₩- | -7.57% |
Book Value vs Market Value Analysis
This analysis compares Helixmith Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.89x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.95x to 1.89x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩6116.47 | ₩5840.00 | x |
| 2017-12-31 | ₩5884.86 | ₩5840.00 | x |
| 2018-12-31 | ₩4790.41 | ₩5840.00 | x |
| 2019-12-31 | ₩6645.47 | ₩5840.00 | x |
| 2020-12-31 | ₩7336.78 | ₩5840.00 | x |
| 2021-12-31 | ₩5983.83 | ₩5840.00 | x |
| 2022-12-31 | ₩5338.01 | ₩5840.00 | x |
| 2023-12-31 | ₩3144.48 | ₩5840.00 | x |
| 2024-12-31 | ₩3093.96 | ₩5840.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Helixmith Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -10.86%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -311.04%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 1.05x
- Recent ROE (-10.86%) is above the historical average (-16.83%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | -3.21% | -36.37% | 0.07x | 1.32x | ₩-6.96 Billion |
| 2011 | -20.32% | -265.82% | 0.06x | 1.21x | ₩-15.09 Billion |
| 2012 | -7.19% | -119.15% | 0.06x | 1.05x | ₩-11.08 Billion |
| 2013 | 0.40% | 4.62% | 0.08x | 1.04x | ₩-6.43 Billion |
| 2015 | 0.38% | 3.34% | 0.11x | 1.05x | ₩-6.46 Billion |
| 2016 | -0.42% | -10.44% | 0.04x | 1.04x | ₩-17.81 Billion |
| 2017 | -3.95% | -205.70% | 0.02x | 1.09x | ₩-22.94 Billion |
| 2018 | -21.46% | -918.70% | 0.01x | 2.12x | ₩-42.12 Billion |
| 2019 | -54.73% | -2402.89% | 0.01x | 1.90x | ₩-126.59 Billion |
| 2020 | -29.99% | -1924.95% | 0.01x | 1.73x | ₩-110.49 Billion |
| 2021 | -22.60% | -2199.16% | 0.01x | 1.25x | ₩-73.47 Billion |
| 2022 | -20.08% | -1555.16% | 0.01x | 1.17x | ₩-65.22 Billion |
| 2023 | -41.58% | -1525.33% | 0.02x | 1.47x | ₩-79.50 Billion |
| 2024 | -10.86% | -311.04% | 0.03x | 1.05x | ₩-29.72 Billion |
Industry Comparison
This section compares Helixmith Co. Ltd's net assets metrics with peer companies in the Food & Tobacco industry.
Industry Context
- Industry: Food & Tobacco
- Average net assets among peers: $86,389,779,784
- Average return on equity (ROE) among peers: 7.84%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Helixmith Co. Ltd (084990) | ₩138.57 Billion | -3.21% | 0.04x | $126.21 Million |
| MSC Co. Ltd (009780) | $28.51 Billion | 3.06% | 2.50x | $22.92 Million |
| KC Feed Co. Ltd (025880) | $48.99 Billion | 4.84% | 1.25x | $23.29 Million |
| FarmStory Co. Ltd (027710) | $148.69 Billion | -4.00% | 3.43x | $53.59 Million |
| EASY BIOInc (353810) | $66.17 Billion | 23.49% | 1.60x | $85.89 Million |
| H.Pio Co. Ltd. (357230) | $139.59 Billion | 11.80% | 0.29x | $10.09 Million |